Coronavirus: Japan infection rate has picked up since Feb. 12

Japan's coronavirus infection rate has picked up since Feb. 12, doubling every four days, according to Jim Bianco, President of Bianco Research.

As of Feb.17, there were 61 confirmed cases of infection compared to 25 on Feb. 12.

Japan's Finance Minister Taro Aso was out on the wires early Tuesday assuring markets that the government is closely monitoring the effects of the virus and will take fiscal measures to counter slowdown as needed.

Dale Fisher, chair of the Global Outbreak Alert & Response Network, that is coordinated by the World Health Organization, warned earlier this month that coronavirus outbreak may be peaking in China but it is just beginning in the rest of the world and likely to spread.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.